Navigation Links
Innovative BioDefense Introduces Zylast Antiseptic Lotion
Date:7/30/2013

LAKE FOREST, Calif., July 30, 2013 /PRNewswire/ -- Innovative BioDefense Inc., the developer of a full product line of Zylast™ antiseptic products for use in healthcare, nursing, food preparation, schools, cruise ships, and homes, introduces Zylast Lotion, available in 2 & 8 oz bottles, or in ADA-approved, wall-mounted dispensers.  Zylast Lotion is protected by patents and other intellectual property and can be viewed at http://bit.ly/12nLtjt

In clinical and laboratory studies, Zylast Lotion has been demonstrated to kill very rapidly a wide spectrum of germs, including E. Coli (99.9999%), S. Aureus (99.9997%), K. Pneumoniae (99.9999%), and S. Pyogenes (99.9999%), while being persistent for six hours after application.  The active ingredient is benzethonium chloride (BZT, 0.2%), together with a proprietary blend of adjuvants that enhance the persistence and rapid kill.  Innovative BioDefense has posted Time-Kill and Persistence papers on its website at www.zylast.com with information on the study results.

Clinical studies have shown that use of Zylast Lotion reduces illness absenteeism in schools by 41.6% among students and 24.7% among teachers and staff.  The Lotion is all-natural, water-based, and Triclosan-free.

"First, the Zylast products are persistent for six hours, so children are protected beyond the 15-second lifespan of an alcohol sanitizer.  Second, the Zylast Lotion is effective against pathogens like the Norovirus, rotavirus, and the common cold – some of the most prevalent diseases among children, and germs against which alcohol sanitizers are relatively ineffective.  Finally, the product is water-based and moisturizes the hands, so children and staff actually like using it, which greatly improves compliance." – Dr. Beth McNichol

Zylast Lotion should be used by healthcare and dental workers, teachers and school personnel, food preparers and servers, parents and in long-term care facilities in order to help assure that harmful bacteria and viruses are killed and the likelihood of contagion reduced.

The retail cost of Zylast Lotion is $71.52 for a case (24 bottles) of 2 ounce bottles or $2.98 a bottle; $106.56 for a case (12) of 8 ounce bottles or $8.88 a bottle; or 178.26 for a case (six) of 1,000 ml (33.8 ounce) cartridges for wall mounting or $29.71 a cartridge. Automatic and manual dispensers are also available.

The product is available for immediate delivery and can be ordered by visiting www.zylastdirect.com.

About Zylast
Zylast™ is a developer, manufacturer and marketer of a full line of antiseptic products for use by healthcare professionals, businesses and consumers.  Zylast products, based on proprietary and patented combinations of pharmaceutical ingredients, are owned by Innovative BioDefense Inc., a privately held company headquartered in Lake Forest, CA. 

For more information, visit www.zylast.com.


'/>"/>
SOURCE Innovative BioDefense Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Innovative Cancer Treatment Supported by NICE
2. Innovative Krebsbehandlung wird von NICE unterstützt
3. UBM Canon and MD+DI Proudly Announce 27 Innovative Products as Winners of the 2013 Medical Design Excellence Awards
4. Andrews Institute offers innovative technology for spine surgery
5. Sirtex To Distribute Surefire Medicals Innovative Infusion System in Australia and Asia Pacific Markets
6. Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies
7. Romanoff Joins Innovative Statewide Program to Combat Abuse of Prescription Pain Medications
8. Neiman Center Issues Policy Brief Outlining Innovative Health Care Payment Models to Provide Cost-Effective Specialty Care for Patients
9. BlueBin Inc. Launches to Deliver Innovative Overhaul for Ailing Healthcare Supply Chain
10. VUCA Health Announces Rapid Adoption of its MedsOnCue Digital Patient Engagement Solution Supporting Health Literacy by Innovative Pharmacies across 19 States
11. TechAtlas Group Releases Innovative Chronic Kidney Disease Landscape Map
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... , Feb. 4, 2016 Summary Breast ... cancer and the most common cancer in women worldwide, ... disease exceedingly prevalent. The number of women diagnosed with ... but the number of deaths has declined due to ... treatment has been revolutionized in the past four decades, ...
(Date:2/4/2016)... Feb. 4, 2016 Mettler-Toledo International Inc. (NYSE: ... 2015.  Provided below are the highlights: , ... compared with the prior year.  Reported sales decreased 3% ... quarter. , Net earnings per diluted share as ... prior- year period.  Adjusted EPS was $4.65, an increase ...
(Date:2/4/2016)... 2016  Blueprint Medicines Corporation (NASDAQ: BPMC ... selective investigational kinase medicines for patients with genomically ... board of directors of Lonnel Coats , ... of industry-related experience. Jeffrey Albers ... strong strategic experience developing and commercializing numerous oncology ...
Breaking Medicine Technology:
(Date:2/6/2016)... IL (PRWEB) , ... February 06, 2016 , ... ... recovery phases of eating disorder treatment helps to reduce the frequency and level ... of the Recovery Phase: Re-Establishing Healthy Identity and Purpose,” will explore the critical ...
(Date:2/5/2016)... ... February 05, 2016 , ... Successful recruitment ... new clinical and scientific initiatives have all marked the last 12 months at ... and CEO of the nation’s oldest cancer center, Candace S. Johnson, PhD, outlined ...
(Date:2/5/2016)... ... February 05, 2016 , ... Freed-Hardeman University President Joe ... signed a joint enrollment and degree completion agreement. The agreement, which begins ... degrees at FHU|Dickson. , The agreement allows students to be jointly admitted ...
(Date:2/5/2016)... ... ... The American public tends to feel uncomfortable about drinking recycled waste water ... well water. The recent experience with lead contaminated water in Flint, Michigan, according to ... increasing public acceptance of recycled waste water as drinking water. , The Flint ...
(Date:2/5/2016)... , ... February 05, 2016 , ... At its annual ... Patrick McDermott as Chairman of the National Board of Directors. Mr. McDermott succeeds former ... the Board,” stated Leslie A. Chambers , APDA President and CEO. “Pat has ...
Breaking Medicine News(10 mins):